Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
iTeos Therapeutics
Biotech
iTeos, reeling from TIGIT fail, is latest prize for Concentra
Concentra is living up to its reputation of buying battered biotechs, swooping in to grab iTeos after the failure of its GSK-partnered TIGIT drug.
James Waldron
Jul 21, 2025 9:36am
Biopharma layoffs hit 4-year monthly high in May
Jul 8, 2025 2:26pm
How 'overenthusiasm' led to Big Pharma's risky $6B TIGIT gamble
Jun 13, 2025 8:00am
Adios, iTeos: Biotech folds weeks after GSK TIGIT termination
May 28, 2025 9:19am
GSK axes $625M TIGIT drug as midphase data disappoint
May 13, 2025 9:44am
iTeos drops one of 3 clinical assets from pipeline
Dec 12, 2024 3:10pm
